Cargando…
Regular, low-dose methadone for reducing breathlessness in people experiencing or at risk of neurotoxic effects from morphine: A single-center case series
Breathlessness is a common symptom suffered by people living with advanced malignant and non-malignant diseases, one which significantly limits their quality of life. If it emerges at minimal exertion, despite the maximal, guidelines-directed, disease-specific therapies, it should be considered pers...
Autores principales: | Sobanski, Piotr Z., Currow, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760708/ https://www.ncbi.nlm.nih.gov/pubmed/36544498 http://dx.doi.org/10.3389/fmed.2022.925787 |
Ejemplares similares
-
Patients’ and their caregivers’ experiences with regular, low-dose, sustained-release morphine for chronic breathlessness associated with COPD: a qualitative study
por: Ferreira, Diana, et al.
Publicado: (2022) -
Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial
por: Janowiak, Piotr, et al.
Publicado: (2017) -
P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease
por: Altree, T, et al.
Publicado: (2022) -
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
por: Currow, David, et al.
Publicado: (2017) -
Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
por: Date, Kathryn, et al.
Publicado: (2023)